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SUMMARY 
We screened a collection of 4847 haploid knockout strains (EUROSCARF collection) of Saccharomyces 
cerevisiae for iron uptake from the siderophore ferrioxamine B (FOB).  A large number of mutants showed 
altered uptake activities, and a few turned yellow when grown on agar plates with added FOB, indicating 
increased intracellular accumulation of undissociated siderophore. A subset consisting of 197 knockouts with 
altered uptake were examined further for regulated activities that mediate cellular uptake of iron from other 
siderophores or from iron salts. Hierarchical clustering analysis grouped the data according to iron sources 
and according to mutant categories. In the first analysis, siderophores grouped together with the exception of 
enterobactin, which grouped with iron salts, suggesting a reductive pathway of iron uptake for this 
siderophore. Mutant groupings included three categories: i) high FOB uptake, high reductase, low ferrous 
transport; ii) isolated high or low FOB transport; and iii) induction of all activites. Mutants with statistically 
altered uptake activities included genes encoding proteins with predominant localization in the secretory 
pathway, nucleus and mitochondria. Measurements of different iron uptake activites in the yeast knockout 
collection makes possible distinctions between genes with general effects on iron metabolism and those with 
pathway specific effects. 
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Abbreviations: FOB, ferrioxamine B; FCH, ferrichrome; CG, coprogen; ENB, enterobactin; TAF, triacetylfusarinine 
C; FC, ferricrocin; BPS, bathophenanthroline disulfonic acid; ORF, open reading frame. 
 
INTRODUCTION 
 Recent advances have made possible 
genome wide approaches to the biology of 
eukaryotes.  Many genes and proteins implicated in 
iron metabolism have been identified in the past ten 
years using classical genetic approaches of 
mutagenesis, phenotype screening, complementation 
and homology searching. More recently global 
transcriptome analysis has become possible, and the 
effects of iron manipulations on gene expression have 
been studied.  Using these methods a number of iron 
transporters and regulators have been discovered 
(KOSMAN 2003). However, many things are still 
missing from a complete picture of cellular iron 
metabolism. There must exist mediators of 
intracellular iron trafficking, distribution, organelle 
transport, and processing – few of which are yet 
identified. Regulators coordinating use of iron in 
cofactors such as heme and Fe-S must exist and the 
cofactors must be made, trafficked and delivered to 
target apoproteins. Most of these key components are 
yet to be found. Finally, essential processes such as 
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transcription, translation, protein trafficking, 
organelle biogenesis and secretion are likely to 
influence iron metabolism to different degrees and in 
different manners. A new tool, the haploid knockout 
collection of S. cerevisiae, has recently become 
available. Each strain carries a complete deletion of a 
single ORF, and the collection can be manipulated 
and examined in microtiter well format. We 
wondered whether we could use this collection to 
discover novel genes involved in iron metabolism. 
 The idea underlying this screen is that yeast 
expresses two independent pathways by which iron 
can enter cells – siderophore and reductive (DANCIS 
et al. 1990; LESUISSE and LABBE 1989). Both 
pathways are regulated and responsive to iron 
availability (YUN et al. 2000a). Therefore, random or 
targeted mutations in the genome that alter basic 
processes involved in cellular iron metabolism will 
affect activities for both pathways. By contrast, 
mutations selectively impacting one or the other 
system will be due to altered expression, localization 
or function of pathway specific components.  
 The siderophore pathway mediates iron 
uptake from siderophores (LESUISSE et al. 2001; YUN 
et al. 2000b). These are small molecules that bind, 
solubilize and chelate ferric iron in the environment 
with tremendous affinity. They are synthesized by a 
non-ribosomal enzymatic process and secreted by 
bacteria and fungi, although not by S. cerevisiae. This 
yeast, however, has evolved means for acquiring iron 
from siderophores made by other organisms. Plasma 
membrane transporters belonging to the 
multifacilitator superfamily are required for 
internalization of ferrisiderophore complexes 
(HEYMANN et al. 1999; LESUISSE et al. 1998; YUN et 
al. 2000b). Trafficking into a vesicular compartment 
and release of iron occurs subsequently (KIM et al. 
2002). Intracellular release of iron from siderophores 
is probably mediated by special reductases and/or 
hydrolases. The details of intracellular trafficking of 
ferrisiderophores, iron release from ferrisiderophores 
and iron distribution following release are still 
undefined (reviewed by Haas (HAAS 2003)).  
 The reductive pathway mediates iron uptake 
from ferric chelates (reviewed by Kosman (KOSMAN 
2003)). An externally directed plasma membrane 
ferric reductase activity dependent on Fre1 (DANCIS 
et al. 1992) and Fre2 (GEORGATSOU and 
ALEXANDRAKI 1994) is able to reduce ferric chelates 
of varying composition (including siderophores), 
thereby releasing ferrous iron that can be accessed by 
the high-affinity ferrous transport complex. The latter 
consists of two components, a multi-copper oxidase 
(Fet3) with externally directed oxidase domain and a 
polytopic permease protein (Ftr1) (STEARMAN et al. 
1996).  The two components together mediate high-
affinity transport of iron into the cell, and both are 
required for this activity. Copper plays a special role 
in the reductive pathway, because copper is an 
obligate cofactor for the multi-copper oxidase 
(DANCIS et al. 1994). Copper delivery to the oxidase 
requires cellular copper uptake (mediated by Ctr1 and 
in some strains also by Ctr3) and copper delivery into 
the secretory pathway (mediated by the Atx1 
metallochaperone and the Ccc2 P-type ATPase).  
Thus mutations that interfere with these steps or with 
the integrity of the secretory pathway result in defects 
of reductive iron uptake.  Of note, copper proteins are 
not involved in iron uptake from siderophores 
(KNIGHT et al. 2002; KOSMAN 2003).  
 Both siderophore and reductive pathways for 
iron uptake are regulated in response to iron 
availability.  Induction occurs under conditions of low 
iron and is mediated by binding of the Aft1 or Aft2 
proteins to consensus sequence sites in the promoters 
of target genes (BLAISEAU et al. 2001; RUTHERFORD 
et al. 2001; YAMAGUCHI-IWAI et al. 1996). 
Expression of genes for both reductive and 
siderophore iron uptake are under control of Aft1/2, 
although their regulatory controls are not perfectly 
coordinated; modifying effects of other factors are 
likely to occur on the individual promoters.  For 
example, siderophore uptake seems to turn on in 
response to more severe iron deprivation, and 
reductive iron uptake responds to milder iron 
deprivation. A class of mutants with defects in Fe-S 
cluster assembly exhibits a complex iron regulatory 
phenotype characterized by global effects on basic 
aspects of iron metabolism. Impaired iron-sulfur 
cluster assembly leads to constitutive Aft1/2 
dependent gene expression and pleiomorphic 
phenotypes including activation of both reductive and 
siderophore uptake systems. Within the cells of these 
mutants, iron accumulates within mitochondria and 
iron-sulfur cluster protein activities are deficient. 
(JENSEN et al. 2004). 
 Here we screened a collection of 4847 
haploid knockout strains (collection from 
EUROSCARF) of S. cerevisiae for regulated 
activities that mediate cellular uptake of iron from 
siderophores or from ferric/ferrous salts. We 
identified hundreds of genes with effects on one or 
more of these activities. A subset of these was 
evaluated as homozygous diploid knockouts to 
decrease problems with suppressor mutations.  Some 
of these genes were previously known to be involved 
in iron handling, although most were not previously 
connected to iron metabolism. An advantage of the 
present strategy is that it did not depend on evaluation 
of growth, which can be difficult to score and 
insensitive to subtle changes in iron homeostasis. 
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MATERIALS AND METHODS 
Yeast strains and growth conditions: The entire 
collection of haploid knockout strains and a subset of 
diploid knockout strains of S. cerevisiae (constructed 
in BY4741 and BY4743, respectively) were 
purchased from the European Saccharomyces 
cerevisiae Archive for Functional Analysis 
(EUROSCARF, Frankfurt, Germany). Genotype of 
the wild type strains is: MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0 (BY4741); MATa/MATα; 
his3Δ1/his3Δ1; leu2Δ0/leu2Δ0;met15Δ0/MET15; 
LYS2/lys2Δ0; ura3Δ0/ura3Δ0 (BY4743). The cells 
were grown in the wells of microtiter plates filled 
with complete YPD medium (100 µl medium /well). 
The cells were precultured for 48 h at 30°C without 
agitation and then diluted 10-fold in medium of the 
same composition and cultured for 5 h under the same 
conditions before being used for experiments. For 
quality control, one mutant strain was randomly 
selected from each of 6 plates (YLR363w, YNR031c, 
YML033w, YLR278c, YOR041c, YOR356w) and 
subjected to two PCR reactions for strain verification. 
The primers used were strain specific primers A and 
KanB to detect the deleted gene, and A and B to 
detect the wild-type gene.  Primers were listed on the 
web site for the Saccharomyces Genome Deletion 
Project.  In each case, the correct deleted gene was 
detected and the wild-type allele was not detected, 
indicating that the well contained the correct strain 
deletion and furthermore that there was no evidence 
of contamination with other yeast strains.  
Screens for siderophore uptake: The 55Fe-labeled 
siderophore (FOB, FCH, TAF or ENB) was added to 
the wells of the culture plates at a final concentration 
of 1 µM, and the cells were grown for 2 h at 30°C. 
The cells were then collected with a cell harvester 
(Brandel) and washed with water on the filter 
(Wallac) before scintillation counting (Wallac Trilux 
MicroBeta).  
Ferric reductase and ferrous uptake assays: Cells 
were inoculated and grown as described above.  After 
the 5 h growth at 30°C, the microtiter plates were 
centrifuged 1500 x g for 5min.  The medium was 
aspirated, and the cells were washed twice in ice cold 
50 mM citrate pH 6.6, 5 % D-glucose and 
resuspended in 100 µl of the same. Optical density of 
the cell suspension was measured.  For measurement 
of ferric reductase activity, 80 µl of the cell 
suspension was aliquoted to a fresh 96-well plate, and 
the assay solution of citrate buffer containing final 
concentrations of 1 mM ferric ammonium sulfate and 
1 mM bathophenathrolinedisulfonate (BPS) was 
added.  After 2 h incubation, absorbance of the 
ferrous-BPS complex was measured at 515 nm. The 
remaining cells were resuspended in 1 µM 55Fe citrate 
and incubated at 30°C.  After 1h, the cells were 
harvested (Tomtec Mach III M) onto fiber filters 
(Wallac).  The filters were allowed to dry, and they 
were then soaked in scintillation fluid (Wallac 
BetaPlate Scint) before being counted using a 96-well 
liquid scintillation counter (Wallac Microbeta LS).  
Clustering of data: Mutant strains with similar 
patterns of activities for iron reductase, ferrous iron 
uptake and siderophore iron uptake were identified by 
clustering analysis of the numerical data. Activities in 
the mutant strains were normalized by reference to 
the wild-type values, and these ratios were expressed 
as log base 2. We used the Cluster 3.0 software 
developed by Eisen et al. (EISEN et al. 1998) and 
modified by de Hoon et al. (DE HOON et al. 2004) to 
perform k-mean clustering (k=10) of the data, with 
uncentered correlation for similarity metric for both 
strains (row) and activities (columns). Cluster 3.0 was 
retrieved at http://bonsai.ims.u-
tokyo.ac.jp/~mdehoon/software/cluster 
The output was visualized using the JavaTreeView 
software written by A. Saldanha (available at 
http://genome-www.stanford.edu/~alok/TreeView). 
 
Statistical Analysis: The diploid strains assayed for 
ferric reductase and ferrous uptake activities were 
assayed a total of four times. A regression analysis in 
the context of ANOVA was used to compare each 
mutant strain to the wild-type (BY4743) to test for 
statistical differences.  The regression is equivalent to 
multiple paired tests of each mutant with the wild 
type, in turn.  The underlying model for the ANOVA 
assumes that the population variances in each gene 
group are equal.  A comparison of variances of the 
wild-type and the pooled mutants showed no 
significant difference in variances between the two 
groups.  Significance level was set at p-value <0.05. 
RNA analysis: For experiments requiring RNA 
isolation, cells were grown in complete YPD medium. 
After overnight pre-culture, the cells were diluted 10-
fold and grown for 5 h at 30°C before RNA isolation. 
RNA was extracted as described previously (KOHRER 
and DOMDEY 1991). Northern blotting (using 20 µg 
of total RNA) and hybridization (at 42°C in 50% 
[vol/vol] formamide) were done essentially as 
described (SAMBROOK et al. 1989). The 32P-labelled 
DNA fragments used as probes came from PCRs with 
the following primer sets : FET3 (623-bp) : 5’-
TTCTTGGACGATTTCTACTT-3’ and 5’-
GCAACTCTGGCAAACTTCTA-3’; SIT1 (872-bp) : 
5’-ACGCTAACCACATCTTCTCC-3’ and 5’-
TAACACTACAACCCAACCAA-3’; A 1.2-kb 
BamHI-HindIII fragment was used for the ACT1 
gene. 
Other: The desferri-siderophores CG and ENB were 
purchased from EMC microcollection GmbH 
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(Germany). Desferri-FCH was purchased from 
Sigma. FOB refers to the commercially available 
mesylate derivative, Desferal (Novartis AG). TAF 
was a gift from Dr H. Haas (Department of Molecular 
Biology, Medical University of Innsbruck, Austria).  
Protoplasts were lysed and fractionated to purify 
isolated mitochondria as previously described 
(RAGUZZI et al. 1988). 
 
RESULTS AND DISCUSSION 
Initial screening of the haploid knockout collection 
for FOB uptake rates: The collection of haploid 
knockout strains was evaluated using a quantitative 
assay for radioactive iron uptake from FOB. Results 
of the screen are shown as a scattergram (Fig. 1), and 
they show a wide distribution of activities, with about 
10% of clones exhibiting increased activity of greater 
than 1.8 fold wild type. The number of clones 
exhibiting decreased activity (less than 0.6 fold wild 
type) was significantly less, amounting to about 1%, 
but this may be due to lowered detection sensitivity 
for a decreased FOB uptake phenotype. The assays 
were repeated 3 times and a subset of strains with 
reproducibly abnormal uptake was selected for further 
study.   
 The FOB ferrisiderophore complex is 
colored yellow brown, whereas the iron free 
siderophore is uncolored. Yeast strains, such as 
AFT1-1up, that accumulate FOB, yet are unable to 
dissociate the iron from the siderophore form 
distinctive yellow colonies (LESUISSE et al. 2001). We 
screened the whole collection of haploid mutants for 
this phenotype. Seven mutants turned yellow due to 
accumulation of undissociated FOB (Fig. 2). SPT4 
(YGR063c, involved in RNA elongation) and 
YGR064w (unknown function) are overlapping 
genes, and thus further study will be required to 
establish which of these two genes is responsible for 
the observed phenotype. Other strains showing the 
same phenotype were mutated in CIK1 (involved in 
organization of microtubule arrays), TIM18 
(translocase of the inner mitochondrial membrane), 
GGA2 (adaptor protein involved in Golgi to vacuole 
transport of special protein substrates), GGC1 (which 
we previously described as YHM1 (LESUISSE et al. 
2004), a GTP/GDP exchanger of the mitochondrial 
inner membrane (VOZZA et al. 2004) that is involved 
in mitochondrial iron homeostasis). Finally, 
YLL029w encodes a gene with unknown function 
(Fig. 2). The color of colonies grown on FOB-
containing agar plates was not directly related to the 
rate of FOB uptake by the cells, as illustrated by the 
ARF1 mutant which showed high FOB uptake and no 
color change indicative of ferrisiderophore 
accumulation (Fig. 2). The colored colony phenotype 
therefore must reflect a specific defect in intracellular 
FOB dissociation that is separate from induction of 
the rate of cellular FOB uptake. Little is known about 
the mechanisms of intracellular iron release from 
internalized siderophores in S. cerevisiae. 
Theoretically, iron could be released from 
siderophores within cells by reduction of the chelated 
iron or by hydrolysis of the siderophore itself. The 
process could take place in a vesicular compartment 
or in the cytoplasm and might involve regulatory 
effects depending on mitochondrial function. The 
effects on this process observed in the mutants 
identified here could be direct or indirect. For 
example, Tim18, a chaperone protein of the IMS is 
involved in translocation and membrane insertion of 
carrier proteins.  Ggc1 is such a carrier protein and 
therefore likely to depend on Tim18 function for 
correct localization and folding. Guanine nucleotides 
in turn are the substrate for Ggc1.  Levels of guanine 
nucleotides apparently affect iron homeostasis and 
might influence siderophore iron release as well, 
although how these effects occur is unknown. The 
FOB accumulator phenotype of AFT1-1up mutants 
could indicate that Aft1 target genes mediate the 
effect, although none of the genes identified here are 
Aft1 regulated.   
 Candidate gene(s) for proteins directly 
participating in iron dissociation from FOB (some 
reductase or hydrolase, for example) were not 
identified here. Perhaps this is due to the nature of the 
screen itself. Mutant cells unable to dissociate 
siderophores at the intracellular level are expected to 
show increased siderophore uptake compared to wild-
type cells when grown on siderophore-containing 
medium (because undissociated iron will be 
unavailable for Aft-mediated sensing). In the present 
screen, we selected strains grown on siderophore-free 
medium that showed high FOB uptake, thus 
excluding putative mutants that would show 
unrepressed siderophore uptake because of a defect in 
siderophore iron sensing. In summary, the data of Fig. 
2 show that YGR063c/ YGR064w, YLL029w, CIK1, 
TIM18, GGA2 and GGC1 are involved, maybe 
indirectly but specifically, in iron removal from 
intracellular FOB. 
 Our screen revealed that a special category 
of mutants was deregulated for FOB uptake: mutants 
that were affected in mitochondrial functions 
frequently showed high (1.5-2 fold the wild-type 
value) or very high (more than 2 fold the wild-type 
value) FOB uptake rates. This was the case for 
mutants deleted from genes encoding mitochondrial 
ribosomal proteins (MRP(L) genes), for ∆cox  
mutants and for ∆atp  mutants (data not shown). We 
are currently studying these categories of mutants 
further in order to discriminate between specific 
effects and effects related to the rho minus status of 
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mutants. Results of this study will be presented 
elsewhere. 
 During the course of working with the 
haploid mutants, we noticed that numerous strains 
showed changes in their uptake rates from one assay 
to the next.  The changes were invariably from high 
uptake to lower uptake, and the changes became more 
pronounced over time and with repeated assaying 
(Table I). We previously found that ssq1 and yfh1 
mutant strains developed extragenic suppressor 
mutations in the genes mediating cellular iron uptake 
(LESUISSE et al. 2003; STEARMAN et al. 1996), and 
iron accumulation has been shown to produce a 
mutator phenotype (KARTHIKEYAN et al. 2002). We 
therefore became concerned that extragenic 
suppressor mutations arising in high uptake mutant 
strains of the haploid knockout collection might be 
obscuring the true phenotypes.  At this point, the 
haploid knockouts identified by the primary screen 
were re-acquired as diploids carrying deletions of the 
corresponding ORFs. We reasoned that these would 
maintain more stable phenotypes, since recessive 
suppressor mutations would not be expressed.  We 
also acquired the wild type, BY4743, and seven 
additional homozygous diploid mutants of genes 
previously characterized in iron  uptake and 
homeostasis (FTR1, FET3, CTR1, ATX1, CCC2, 
SSQ1, and YHM1) to serve as controls. 
 
Analysis of uptake from various siderophores: A 
subset of the homozygous diploid mutants that 
showed a clear FOB uptake phenotype was analyzed 
for iron uptake from four different siderophores  
(FOB, FCH, TAF, ENB). To further parse phenotypic 
categories, iron and copper content of the growth 
medium was manipulated, and reductase and ferrous 
iron uptake activities were measured. This first 
analysis sheds light on the overlap or differences 
among iron uptake pathways. The data are shown in 
Fig. 3. Each vertical column depicts data for a 
particular type of iron uptake assay –ferric reductase, 
ferrous iron uptake, or siderophore iron uptake. Each 
horizontal row depicts the results for a single 
knockout clone, constructed by replacement of the 
open reading frame for a single gene, indicated by 
ORF number and name. The data represent mean 
values of triplicate measurements and are color 
coded, with red representing relative increased 
activity and green representing relative decreased 
activity compared to the parental control strain. The 
clustering software grouped the iron assays into three 
main nodes. The left-hand node consists in ferric 
reductase activity, measured following growth with 
low copper (-Cu), copper replete (+Cu) or low iron 
(BPS). These correspond to moderately inducing, 
repressing and maximally inducing conditions. The 
middle node groups ENB uptake with ferrous uptake, 
following low copper (-Cu) or copper replete (-Cu) 
growth.  The right hand node groups siderophore 
uptake from FOB, FCH or TAF.  What is 
immediately clear is that although these activities 
involved in iron acquisition may sometimes be 
coordinately expressed, they more often show 
divergent levels of expression. The divergences are 
particularly informative here, and we will discuss 
several examples.  
1) Horizontal nodes 2, 3. In these groups of 
mutants, ferrous uptake was low (green) and 
associated with increased ferric reductase activity 
(red). Uptake activities from siderophores FOB, FCH 
and TAF were increased (red). We can understand 
these phenotypes as consequences of a primary 
problem with ferrous iron transport, and a secondary 
regulatory response. Iron in the growth medium was 
present as ferric iron chelates, and so an interruption 
of ferrous transport will result in cellular iron 
depletion and generation of an iron starvation signal. 
Thus when uptake activities were measured, ferrous 
transport was low, and ferric reductase was high due 
to iron starvation. Similarly siderophore transport 
activities were induced by iron starvation experienced 
during growth of the cells.  
2) Horizontal nodes 1 and 9. In these groups 
of mutants, the most striking finding is a singular 
increase in uptake activity for the siderophore FOB. 
The effect is unlikely to represent a regulatory effect 
from iron starvation occurring during growth, 
because, as stated above, FOB iron was not present in 
the growth media. Furthermore, other iron-regulated 
activities, e.g. reductase, were not induced. We are 
left with the conclusion that FOB uptake was 
specifically altered, implying a regulatory signal 
specific for FOB uptake or a more direct gain of 
function effect on components of the uptake pathway.   
 3) Horizontal node 5. In node 5, the FOB 
and FCH uptakes were increased, while other 
activities remained unperturbed. Again, these effects 
are unlikely to be the result of general misregulation 
of iron metabolism, because other reductase and 
ferrous transport were unaffected. The effects could 
be due to regulatory signals or upregulation of 
components shared by FOB and FCH uptake 
pathways.   
 4) Horizontal node 6. In two mutant strains, 
∆sit1 and ∆deg1, iron uptake activities from FOB and 
FCH were decreased, whereas other activities were 
minimally altered. SIT1 encodes a member of the 
multifacilitator family implicated in uptake of 
siderophores at the plasma membrane. The substrate 
specificity for Sit1p shows preference for FOB but 
also includes FCH (LESUISSE et al. 2001). The deg1 
deletion strain phenocopies ∆sit1, raising the 
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possibility that Deg1p modulates SIT1 expression or 
acts downstream of Sit1p in siderophore uptake. 
However, the decreased FOB and FCH uptake in 
these knockout mutants mirrors the increased FOB 
and FCH uptake in other mutants (horizontal blocks 
5), indicating the existence of a specific trafficking 
pathway for handling of these two siderophores.   
 5) Horizontal nodes 3, 5, 6, 10 (and to a 
lesser extent, 7). These groups show unique behavior 
for the TAF uptake activities, which remained 
unperturbed in the face of increased or decreased 
activity for transport of the other siderophores. 
However, in some cases TAF uptake seemed to move 
with the other transport activities and was clearly iron 
responsive. A possible explanation for these data is 
the existence of a threshold effect; for example, a 
lower affinity Aft1 binding site on a MFS member 
promoter mediating TAF uptake could be envisaged. 
Another possibility, which does not exclude the 
previous one, is that TAF uptake and use involves 
different pathways of regulation and/or trafficking. 
This hypothesis is strengthened by our previous 
observations that the presence of TAF did not 
interfere with the uptake of other siderophores (FCH, 
FOB or FC) which themselves showed complex 
relationships of competitive inhibition for uptake 
(LESUISSE et al. 2001; LESUISSE et al. 1998). In 
addition, we observed that the Cyc8-Tup1 repressor 
had opposite effects on the uptake of FOB/FCH and 
on the uptake of TAF (LESUISSE et al. 2001). 
 6) Horizontal node 8. In this node, the 
mutant strains showed increased cell reductase 
activity whatever the growth conditions and increased 
uptake activity whatever the iron source. This 
suggests that the strains grouped in this node suffer 
from a general misregulation of iron metabolism, as 
shown for mutants of mitochondrial iron homeostasis 
(yfh1, nfs1, isu1/2 etc…(FOURY and TALIBI 2001; 
GERBER et al. 2004; LI et al. 1999)). Interestingly, 4 
out of 6 strains of this node were deleted for a gene 
encoding a mitochondrial protein (IMG2, YME1, 
MTM1 and YHM1/GGR1), highlighting once more the 
importance of the mitochondrial compartment for 
cellular iron homeostasis.  
 7) Vertical column for ENB uptake.  ENB 
uptake was found to group with ferrous transport 
activities rather than with other siderophore transport 
activities. Siderophores bind ferric iron with high 
affinity but ferrous iron with low affinity. Following 
reduction of the ferrisiderophore complex, ferrous 
iron could be released and permeated into the cell via 
the Fet3/Ftr1 ferrous transport complex (LESUISSE 
and LABBE 1989; YUN et al. 2000a). Grouping of the 
ENB data with the ferrous transport data suggests that 
iron bound to ENB was taken up via a reductive 
pathway, and that a specific MFS member was not 
involved. We sought direct confirmation for this by 
measuring iron uptake from various iron sources in a 
∆fre1∆fre2 mutant strain which lacks cell surface 
ferrireductase activity (GEORGATSOU and 
ALEXANDRAKI 1994). Results are shown in Fig. 4. As 
expected, uptake of ferric citrate was decreased in the 
reductase-negative mutant compared to wild-type 
cells (Fig. 4). This was also the case for coprogen 
(CG), a siderophore for which no specific receptor 
has been found in S. cerevisiae (LESUISSE et al. 
1998). Uptake of hydroxamate-type siderophores for 
which a specific non-reductive uptake pathway has 
been shown unambiguously in S. cerevisiae (FOB, 
FCH, TAF), was unaffected –or even increased- by 
the loss of cell surface reductase activity (Fig. 4). 
However, uptake of the catecholate-type siderophore 
ENB was strongly decreased in reductase-deficient 
cells (Fig. 4). These results suggest that iron uptake 
from ENB follows a reductive pathway, and that the 
putative siderophore transported via the ENB1 gene 
product remains to be identified. Another possibility 
is that a specific transporter for enterobactin 
(HEYMANN et al. 2001) could still exist and might 
be completely repressed in complete medium. 
 
Analysis of gene groups with characteristic 
phenotypes for reductive or non-reductive uptake: 
In independent experiments, a set of 110 
homozygyous diploid mutants, seven control strains 
(FTR1, FET3, CTR1, ATX1, CCC2, SSQ1, and 
GGC1) and wild-type (BY4743) were analyzed for 
iron uptake from FOB (siderophore pathway) and 
ferrous ascorbate (reductive pathway). Ferric 
reductase was also measured, and iron and copper 
content of the growth media were manipulated. The 
clustering analysis grouped the data to identify 10 
phenotypically similar groups of mutants. These 
phenotypic groups could be clustered into three more 
general categories. The defining characteristic of the 
first category was low ferrous iron transport activity 
(Fig. 5A). The hallmark of the second category was 
specific alteration, (high or low) of FOB uptake 
activity (Fig. 5B). Finally, mutants in the third 
category exhibited generalized induction of all iron 
transport activities compared with wild-type controls 
(Fig. 5C). In each category, a few strains were 
assayed for their level of FET3 and SIT1 RNAs by 
Northern blotting (Fig. 5). 
1) Low ferrous uptake. The first category, 
characterized by low ferrous iron transport, includes 
knockouts of genes with known functions in iron 
metabolism (Fig. 5A). Within this category, the aft1 
deletion mutant exhibited a unique phenotypic profile 
of decreased FOB transport activity and decreased 
ferrous transport activity (node A-1). Basal and 
induced ferric reductase levels were maintained, 
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perhaps because of the ability of alternate 
transcription factors such as the copper sensing 
Mac1p (or Aft2p) to mediate expression in the 
absence of Aft1p (BLAISEAU et al. 2001; 
GEORGATSOU et al. 1997). UME6 (node 5A-1) 
knockouts exhibited some aspects of the ∆aft1 
phenotype, and the encoded protein (a zinc finger 
transcription factor) may therefore play a role in iron 
sensing. FET3 and FTR1 are known Aft1p target 
genes. FET3 encodes a multicopper oxidase, and the 
encoded protein is associated with Ftr1p to form the 
plasma membrane transporter complex for high-
affinity ferrous uptake (STEARMAN et al. 1996). Thus, 
as expected, FET3 and FTR1 knockouts showed 
negligible high-affinity ferrous transport activity 
(node 5A-1). These mutants clustered here, although 
they differed from the AFT1 deletion phenotype in 
that FOB uptake was not decreased in mutants of the 
ferrous transporter.  Surprisingly, FOB uptake and 
ferric reductase were not induced in these iron 
transport mutants, implying that inactivation of the 
ferrous transporter does not by itself produce severe 
iron starvation. Other iron acquisition pathways such 
as low affinity iron transporters (DIX et al. 1997) 
likely can function in rich media to supply adequate 
iron to prevent starvation. This was confirmed by 
northern blotting FET3 and SIT1 mRNAs from the 
∆ftr1 mutant and from wild-type cells: transcription 
of these genes was only slightly increased in the 
mutant (Fig. 5). 
 Mutants blocked in riboflavin biosynthesis 
(∆rib4, node 5A-1) also showed deregulation of iron 
metabolism. However, the phenotype of the haploid 
∆rib4 strain differed from that of the diploid ∆rib4/∆ 
strain, and both the haploid and diploid strains tended 
to accumulate extragenic suppressor mutations (data 
not shown). The effect of riboflavin synthesis on iron 
metabolism will be described elsewhere. 
 Node 5A-2 clusters data for mutants of 
CTR1, CCC2, and ATX1. These mutants exhibited 
low ferrous transport activity, high ferric reductase 
and high FOB uptake. The corresponding genes have 
established roles in copper transport, and therefore the 
iron regulatory phenotypes of the mutants are likely 
secondary to effects on copper. CTR1 encodes a 
plasma membrane copper transport protein. The 
function of CTR1 is redundant with CTR3. However, 
the latter is inactivated by transposon insertion in 
some yeast genetic backgrounds (including 
BY4741/2), leading to dependence on CTR1 
expression for high-affinity copper uptake and high-
affinity iron uptake (KNIGHT et al. 1996). ATX1 
encodes a copper chaperone, dedicated to delivering 
copper to the P-type ATPase Ccc2p, which in turn 
transports copper into the secretory pathway for Fet3p 
activation. The genes CTR1, CCC2 and ATX1 are 
involved in copper handling and delivery of copper to 
apo-Fet3, and thus the corresponding mutants have 
deficient Fet3 activity accounting for the low ferrous 
transport activities. Another characteristic of node 
5A-2 is greater induction of FOB uptake and ferric 
reductase compared with node 5A-1 (FET3 and FTR1 
mutants for example). Similarly, transcription of 
FET3 and SIT1 were increased compared to wild-type 
levels in the ∆ccc2/∆ strain representative of this node 
(Fig. 5). A possible explanation for these differences 
is provided by the role of Fet5, a multicopper oxidase 
associated with the Fth1 permease in the vacuole 
membrane and dedicated to pumping iron outward to 
the cytoplasm (URBANOWSKI and PIPER 1999). Thus 
copper deficiency or impaired copper trafficking will 
lead to defects in both Fet3 and Fet5 oxidases, with 
consequently more severe cellular iron starvation than 
defects in either oxidase separately. BUD32, PKR1 
and RAV1 knockouts also showed similar phenotypes 
to the copper trafficking mutants, with low ferrous 
uptake partly compensated by copper addition to the 
media and constitutively high FOB uptake (node 5A-
2). The functions of Bud32 and of Pkr1 are unclear, 
but Rav1 is part of a complex named 'regulator of the 
(H+)-ATPase of the vacuolar and endosomal 
membranes' (SEOL et al. 2001) which could be 
involved in copper trafficking in a way that remains 
to be determined 
 Node 5A-3 includes protein sorting mutants 
localized to later stages in the secretory pathway. 
Also included are VMA mutants lacking constituents 
or regulators of the hydrogen transporting vacuolar 
ATPase. The iron phenotype of these mutants 
depended on transcriptional effects on iron transporter 
expression and also probably on post-transcriptional 
effects. Representative mutants of node 5A-3 
(∆pep12 and ∆vma6) showed a significant increase in 
the levels of FET3 and SIT1 transcription (Fig. 5). 
Several mutants (∆pep12, ∆vps15, ∆arf1…) with 
impaired endosome fusion with late endosome and 
vacuolar compartments are expected to exhibit 
decreased recycling of Sit1 (KIM et al. 2002). 
Increased Sit1 at the cell surface in these mutants 
could then enhance cellular uptake of FOB by a post-
transcriptional mechanism.  
 The signature iron phenotype of these 
mutants overlaps that produced by copper deficiency, 
and could be explained by missorting of copper 
transporters and/or copper delivery components. 
Alternatively, disruption of acidification of the 
secretory pathway might interfere with efficient 
copper loading of apoproteins. Consistent with this 
idea, some ferrous transport defects in some of the 
mutants were corrected by growth in high 
concentrations of copper (50 µM added to YPAD). 
The degree of correction was variable. No correction 
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was observed for FET3 and FTR1 mutants as 
expected, since the copper binding target Fet3p is 
absent or retained in the earliest part of the secretory 
pathway. Partial correction was observed for CTR1, 
ATX1 and CCC2 mutants. Some VPS mutants, such as 
∆vps4 and ∆vps9 showed partial correction. The 
phenotypes of these diploid mutants in the BY4743 
background were slightly different from previously 
published experience with haploid mutants in a 
different genetic (YUAN et al. 1997). However, these 
differences are difficult to interpret, because the 
ability of copper to correct ferrous transport defects in 
various mutants is poorly understood. The effects are 
presumed to be mediated by an uncharacterized low-
affinity copper transport pathway able to bypass the 
usual copper delivery pathway to Fet oxidases in the 
secretory pathway.  
 2) Altered FOB transport. The second 
phenotypic category is characterized by altered FOB 
transport activity (Fig. 5B). Iron use from 
siderophores involves a complex machinery regulated 
at transcriptional and post-transcriptional levels. The 
presence of siderophores in the medium has to be 
«sensed» by the cells prior to the siderophore 
receptors being exported at the plasma membrane 
(KIM et al. 2002). Transcription of genes for these 
receptors is itself subject to complex regulation, 
depending on Aft1/2 and Tup1/Cyc8 (LESUISSE et al. 
2001). Iron dependent and iron independent signals 
are integrated in control of these genes. Endocytosis 
and recycling of the siderophore receptors depend on 
the machinery for intracellular protein trafficking, 
involving many regulatory steps at various levels. 
This may explain the high number of genes 
implicated  in FOB uptake and regulation.  
In node 5B-1, FOB uptake was increased but 
reductase and ferrous transport were not altered. In 
node 5B-2, FOB uptake was increased and ferric 
reductase was decreased under some conditions, 
while ferrous transport was variable. The phenotype 
of these mutants was probably not due to direct 
transcriptional effects on the «iron regulon» genes, as 
the levels of FET3 and SIT1 transcription were not 
significantly altered in representative strains (∆gga2, 
∆vam6, ∆ssn8) (Fig. 5). Many genes of these first 2 
nodes (5B-1, 5B-2) are involved in transcriptional 
regulation and RNA processing (LSM1, LSM6, LSM7, 
PAT1, SSN3, CYC8, SSN8, MED1…). Thus, effects 
of these mutants on FOB uptake are likely to be 
indirect (in view of lack of change in SIT1 message 
level in the ∆ssn8 strain). Other genes in this group 
are involved in intracellular protein trafficking 
(GGA2, VAM6, APS3…), and these might influence 
trafficking of siderophores or siderophore receptors. 
One of these genes, GGA2 (block 5B-1), is 
particularly interesting, since the corresponding 
mutant showed strongly increased FOB uptake with 
unaltered SIT1 transcription, while other iron-
dependent activities (reductase and ferrous transport) 
were unchanged. Moreover, TAF uptake by the 
∆gga2 mutant was unaltered (see Fig. 3, node 5), and 
undissociated FOB accumulated in this mutant (see 
Fig. 2). Thus, gga2 mutation creates a specific 
interruption upstream of the dissociation step for FOB 
and FCH. Gga proteins are known to contribute to 
protein sorting by functioning as adaptors between 
cargo proteins and clathrin coats (KATZMANN et al. 
2002). We are currently trying to use the ∆gga2 
mutant as a tool to determine which cellular 
compartment(s) is (are) involved in iron dissociation 
from FOB. 
 The node 5B-3 is very interesting. It includes 
two strains mutated in genes that are anti-sense to one 
another, BUD25 and HEM14. Both strains showed 
markedly increased FOB uptake, strongly decreased 
reductase, and unaltered ferrous transport. Both 
strains showed heme deficiency, although the Hem14 
block in heme biosynthesis is a little leaky, because 
protoporphyrinogen can be oxidized into 
protoporphyrin non-enzymatically to some extent 
(CAMADRO et al. 1994). Both strains were able to 
grow slowly on YPD medium without 
supplementation with hemin or tween/ergosterol. 
Reductase activity of these strains was virtually 
absent, probably due to the lack of heme, which is a 
cofactor for the Fre protein reductases (SHATWELL et 
al. 1996). The observation that these strains showed 
very high uptake of FOB raises the question of the 
role of heme synthesis in iron homeostasis. In a recent 
study, Crisp et al. (CRISP et al. 2003) showed that 
heme-deficient mutants down-regulated genes of the 
«iron regulon». However, regulation of genes 
involved in siderophore uptake by these mutants was 
not examined. The present study shows that SIT1 
transcription was tremendously increased in the 
∆hem14 mutant compared to wild type cells (Fig. 5), 
which could account for the observed phenotype of 
high FOB uptake. In a previous study, we showed 
that some heme mutants showed constitutively high 
FOB uptake (LESUISSE and LABBE 1989). We 
therefore studied this question further, and analyzed 
the influence of global heme deficiency and of 
specific genes (HEM gene family and the BUD25 
gene) on siderophore and ferrous transport. Results of 
this study will be published elsewhere.  
 Node 5B-4 groups strains with low FOB 
uptake activities. As expected, the ∆sit1 mutant was 
found in this group. The influence of HSP12 
disruption on iron metabolism should be studied 
further, because the haploid and diploid mutants 
behaved differently. The haploid ∆hsp12 strain was 
initially selected for high FOB uptake, but tended to 
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loose this phenotype in the successive screens (see 
Table 1), while the diploid ∆hsp12/∆ strain showed 
stable low FOB uptake phenotype. The reason for 
such a discrepancy is unknown. The phenotype of the 
∆deg1 strain resembles the ∆sit1 strain.  DEG1 
encodes a tRNA pseudouridine synthase and may 
play in regulating SIT1 expression or activity. Of 
note, the level of SIT1 transcript was very low in this 
strain (Fig. 5).  
 3) Generalized induction of all activities. 
The third phenotypic category (Fig. 5C) groups 
together mutants that showed highly induced 
reductase, FOB transport and ferrous transport. The 
corresponding ORFs are candidates for genes that 
function in general iron metabolism or iron sensing. 
Many categories of genes are included here, including 
genes for nuclear encoded mitochondrial functions, 
genes implicated in endocytosis, vacuolar protein 
sorting, and transcriptional regulators. Transcriptional 
and post-transcriptional effects were involved in 
producing the mutant phenotypes. One strain taken as 
representative of node 5C-1 (YLL029w) showed a 
moderate increase (about 2-fold) in the level of FET3 
and SIT1 transcripts (Fig. 5). However, iron uptake 
activities were more severely affected (about 5-fold 
increased) suggesting that post-transcriptional 
regulation was also involved. In node 5C-2, a number 
of genes implicated in endocytosis and intracellular 
protein trafficking are grouped together. In contrast to 
what was observed in other endocytosis mutants (see 
strains of node 5A-3), no direct effect on FET3 and/or 
SIT1 transcription was observed here (Fig. 5). Note 
that the biological significance of low ferrous 
transport following growth in the presence of copper 
is unclear, but nonetheless, this characteristic seems 
to enable phenotypic grouping of endocytosis 
mutants. Several of the mutants in this node (∆snf7, 
∆vps20, ∆vps25, ∆vps28, ∆vps36, ∆bro1) are 
expected to be defective in fusion of late endosome 
vesicles to the vacuole (KATZMANN et al. 2002). The 
consequences of this organellar trafficking 
abnormality may be to increase Sit1p concentration at 
the cell surface, leading to increased FOB uptake. In 
addition there may be enhanced surface expression of 
reductase and ferrous transport proteins, leading to 
increased reductase activity and ferrous transport 
activity.   
 
Statistical analysis of mutants with effects on iron 
uptake grouped according to proposed cellular 
localizations of the corresponding gene products: 
The data up to this point have been analyzed using k-
means clustering of uptake and reductase activities to 
group mutants according to phenotypic similarities. 
The multiple biological replicates (n=4) of the data 
for ferrireductase and ferrous uptake allowed us to 
perform a more standard statistical analysis 
(regression in the context of ANOVA) comparing 
each mutant with the wild type. For this analysis only 
diploid mutants that had a FOB uptake rate of less 
than or equal to 0.6X wild type (low) and of more 
than or equal to 1.8Xwild type (high) were included.  
The data from this alternative statistical analysis is 
presented according to the proposed cellular 
localization of the corresponding proteins (from SGD 
GO annotations) in Table 2. For ferric reductase 
activity and ferrous uptake, mutants are described 
with high or low activity if there was a statistical 
difference compared to wild type at a level of p<0.05. 
An overview of this table indicates the majority of 
mutants that had altered FOB uptake also had altered 
ferrireductase activity. However, of the 81 mutants 
that had high FOB uptake only 28 of these had 
significantly altered ferrous uptake (7 had high and 21 
had low ferrous uptake -not including the mutant 
control strains). Likewise, of the five mutants that had 
low FOB uptake only 1 mutant also had abnormal 
(low) ferrous uptake.  Thus comparison of FOB 
uptake with ferrous uptake is likely to be more 
informative than with ferrireductase. The lack of 
correlation between FOB and ferrous uptake in these 
mutants is probably reflective of the functional 
separation of these two pathways in bringing iron into 
the cell.  However, organelles in which the FOB and 
ferrous uptake phenotypes converge might be key 
components of intracellular iron transport or iron 
regulation systems.  
The convergence is particularly apparent at 
the mitochondria where four mutants (∆img2, ∆mtm1, 
∆tom5 and ∆YCR024c) as well as control mutant 
∆ggc1 (formerly ∆yhm1) exhibit high FOB and high 
ferrous uptake (Table 2). Three of the corresponding 
proteins are involved in mitochondrial protein 
biosynthesis or protein import. Img2p is a constituent 
of mitochondrial ribosome complex. YCR024c 
encodes a mitochondrial protein with asparaginyl-
tRNA synthetase activity (LANDRIEU et al. 1997). 
Disruption of either gene generates a petite 
phenotype, although why deletion also generates this 
particular iron phenotype is not clear. Tom5p is part 
of the mitochondria outer membrane translocase 
complex and may serve as a functional link between 
the outer membrane receptors and the general import 
pore of the mitochondria (DIETMEIER et al. 1997). A 
role for this protein in the import of proteins involved 
in Fe-S cluster and/or heme cannot be excluded. The 
effect of Tom5p on cellular iron uptake is likely to be 
post-transcriptional, since disruption of the 
corresponding genes did not significantly alter the 
level of FET3 and SIT1 transcripts (data not shown). 
The corresponding protein for the other mutant in this 
group, Mtm1p is a mitochondrial carrier protein 
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involved in activation of Sod2 (LUK et al. 2003). The 
∆mtm1 mutant was shown to accumulate iron in the 
mitochondria (LUK et al. 2003). Overall the 
phenotype of ∆mtm1 is very similar to that of strains 
defective in mitochondrial Fe-S cluster assembly 
ssq1, nfs1, and the control mutant strain ggc1 
(KNIGHT et al. 1998; LESUISSE et al. 2004; LI et al. 
1999). This convergence of high FOB uptake and 
high ferrous uptake phenotypes in strains with 
mutations of genes encoding mitochondrial proteins 
underscores the importance of this organelle in 
cellular iron homeostasis and lends weight to our 
hypothesis (SANTOS et al. 2003) that a mitochondrial 
Fe-S cluster (that could be sensitive to oxidative 
stress especially by superoxides) performs a 
regulatory function in a signal transduction chain 
from the mitochondria to the cytosol to inform the 
cell of iron status. The majority (21) of the high FOB 
mutants with a defect in ferrous uptake had low 
ferrous uptake. This reciprocal phenotype 
convergence (high FOB, low ferrous uptake) was 
particularly noticeable in mutants whose 
corresponding proteins are located in, or involved 
with the secretory/vacuole system and the nucleus. 
The secretory/vacuolar mutants include ∆pep7, 
∆rav1, ∆vps9, ∆vma6, ∆vma10, and ∆vma13. The low 
ferrous uptake of ∆rav1 and ∆vps9 mutants could be 
suppressed by the addition of copper to the growth 
media, in a manner identical to the control mutants 
∆ccc2 and ∆atx1. Rav1p is involved in the regulation 
of vacuolar acidification and Vps9 is a guanine 
nucleotide exchange factor involved in vacuolar 
protein transport (HAMA et al. 1999).  Although the 
low ferrous uptake phenotype of ∆vam6, ∆vma10, 
and ∆vma13 cannot be corrected by addition of 
copper to the growth media all three corresponding 
proteins are essential in vacuolar acidification. 
Vma6p and Vma10p are subunits of the H(+)-ATPase 
(BAUERLE et al. 1993; SUPEKOVA et al. 1995), and 
Vma13p is required for H(+)-ATPase assembly. 
These data support the idea that a functional vacuole 
is required for normal iron and copper cellular 
homeostasis (DAVIS-KAPLAN et al. 2004; SZCZYPKA 
et al. 1997), when the vacuole is dysfunctional ferrous 
uptake is diminished and the increase in FOB uptake 
is likely the result of a compensatory regulatory 
system.   
The nucleus was also a site for reciprocal 
convergence of high FOB and low ferrous uptake for 
mutants ∆tup1, ∆cyc8, ∆med1, ∆ssn3, and ∆taf1 
(Table 2). The corresponding proteins all mediate 
transcription. We previously showed that the 
Tup1/Cyc8 general repressor complex was involved 
in iron uptake regulation, with preferential effects on 
derepressing the siderophore uptake pathway 
(LESUISSE et al. 2001). At this stage, it is not possible 
to discriminate between factors that directly mediate 
transcription of the “iron regulon” genes and those 
that could act more indirectly. However, the copper 
correction of the low ferrous uptake of the ∆med1 
mutant might suggest that the corresponding protein 
mediates its effect on the genes encoding copper 
transport/distribution proteins.   
Finally in this statistical analysis, one mutant had a 
distinct phenotype of low FOB uptake and low 
ferrous uptake. That mutant was ∆aft1, the well-
characterized iron regulatory transcription factor 
(YAMAGUCHI-IWAI et al. 1995). The uniqueness of 
this mutant phenotype from a primary screen of over 
4847 mutants underscores the critical role Aft1p plays 
in yeast iron homeostasis.  
 
Phenotypic categories and iron distribution: The 
initial screen identified many mutant strains of yeast 
with increased activity for iron uptake from FOB. The 
increased FOB uptake could be a regulatory 
consequence of cellular iron starvation occurring 
during growth (phenotypic category I). Alternatively, 
it could result from specific effects that increase 
siderophore transport into cells (phenotypic category 
II). Finally, increased FOB uptake activity could 
result from a general perturbation of iron sensing and 
iron regulation (phenotypic category III). We next 
evaluated examples of knockout mutants from each 
phenotypic category in terms of their intracellular iron 
distribution following iron loading with FOB as an 
iron source (Table 3). The results show that iron 
distribution was abnormal for mutants from each 
category, with proportionately decreased 
mitochondrial accumulation of iron. In the ∆vma10 
mutant (category I), biogenesis of the vacuolar 
ATPase is disrupted. The iron phenotype was 
characterized by impaired ferrous transport and 
increased FOB uptake activity. When the cells were 
loaded with iron from FOB, cell associated iron was 
increased as expected. However, mitochondrial iron 
was not proportionately increased. In the ∆gga2 
mutant (category II), the FOB uptake was specifically 
induced with no alteration of reductase or ferrous 
transport.  The ∆gga2 mutant had the additional 
phenotype of accumulating colored iron siderophore 
complexes indicating a problem in dissociating them 
or distributing them intracellularly (see above). 
Following iron loading from FOB, cellular iron was 
increased, and again, mitochondrial iron was not 
proportionately increased. In mutants of TOM5, 
POR1, FMC1, IMG2 (category II), mitochondrial 
functions are disrupted to varying degrees and in 
pleiotropic manner. Reductive and FOB transport 
were induced, but again, following loading with iron 
from FOB, mitochondrial iron accumulation was not 
proportionately increased. The implication of all these 
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results is that cellular iron uptake and mitochondrial 
iron accumulation from FOB are subject to separate 
controls. Many of the mutations that impacted on 
cellular iron uptake, inducing FOB transport activity, 
did not induce mitochondrial deposition of the iron. 
This is in contrast to the phenotype of Fe-S cluster 
assembly mutants in which induction of FOB uptake 
activity and mitochondrial iron accumulation are 
salient feature. Two mutants (category III) were 
examined which did not adhere to the pattern 
described above. Instead, they exhibited increased 
iron transport activities (reductase, ferrous transport 
and FOB transport), but following loading with iron 
via FOB, they accumulated mitochondrial iron in 
proportion to cellular iron, and so the ratio of these 
compartmental accumulations was not altered (Table 
3). YLL029w and YGL220w encode uncharacterized 
ORFs. The corresponding proteins are reported to be 
cytoplasmic, and it is interesting to speculate that they 
may coordinately control cytoplasmic and 
mitochondrial iron distribution. YLL029w may be 
especially interesting to study further, since the 
corresponding mutant accumulated FOB as its 
undissociated form (see above). One important 
question that arises from the analysis of iron 
distribution in strains showing increased FOB uptake 
is indeed related to the cellular location where iron 
dissociation from the siderophore takes place. Is iron 
necessarily released from the siderophore before 
entering the mitochondria, or is there some pathway 
for siderophore uptake and use by the mitochondria 
itself? Our iron distribution studies do not answer to 
this question. Mutants known to accumulate iron by 
the reductive pathway followed by iron deposition in 
the mitochondria (∆yfh1, ∆atm1 etc…) also 
accumulate iron from siderophores (LESUISSE et al. 
2001), but the intracellular distribution of this 
siderophore-iron was never investigated. The cells 
deleted for YLL029w accumulated FOB in an 
undissociated form (whole cells were colored after 
growth with FOB), and showed increased iron in their 
mitochondria compared to wild-type cells (Table 3), 
but further work would be required to determine if 
part of the intracellular FOB could be found 
undissociated inside the mitochondria. Mitochondria 
are intrinsically more pigmented than whole cells, and 
thus accumulation of the siderophore pigment into 
this organelle is less obvious to determine than in 
whole cells. We are currently working on these 
questions related to the intracellular dissociation of 
siderophores. 
 
General conclusion and caveats: This study of the 
entire set of viable haploid deletion strains of S. 
cerevisiae from the Euroscarf collection revealed a 
huge number of genes with involvement in cellular 
iron homeostasis. In the initial screen for FOB uptake, 
more than 10% of the mutants (570 strains) showed 
altered activity compared to the wild-type strain. A 
subset with reproducibly abnormal phenotypes was 
selected and analyzed as homozygous diploids (197 
strains including 79 with mutations in COX, ATP and 
MRP(L) genes which will be presented separately). 
Some strains affected in iron metabolism probably 
passed through the net of our successive screens for 
several reasons. First, all the strains that did not show 
altered iron uptake in the first screen were not studied 
further; thus, errors in measuring uptake values in the 
first screen may have led to discarding some 
potentially interesting strains. Second, our screen was 
more sensitive at detecting high FOB uptake strains 
than low FOB uptake strains (for technical reasons 
related to the specific activity of 55Fe we used). 
Finally, a large number of mutants showed an 
unstable phenotype, with progressive attenuation of 
the high uptake phenotype. Probably this was due to 
accumulation of extragenic suppressor mutations. In 
addition, it is important to note that only the strains 
considered as viable in the Euroscarf collection were 
screened. Curiously, mutants with defective Fe-S 
cluster assembly were not selected here. Some were 
classified as essential genes (e.g. YFH1, ATM1) and 
others were missed perhaps due to masking of the 
phenotype by suppressors (e.g. SSQ1). Despite all 
these limitations, in this study a large number of 
genes were implicated in iron metabolism for the first 
time. These included genes encoding predicted 
proteins located in the plasma membrane, cytoplasm, 
secretory pathway, nucleus and mitochondria. Future 
work will endeavor to determine which of these affect 
iron metabolism directly via transport or sequestration 
of iron and which affect iron metabolism indirectly 
via signals or protein trafficking.  
 A special feature of the screen is the 
measurement of distinct uptake systems. One of the 
uptake systems (reductive) is active during growth in 
the usual media and its activity reflects iron 
regulation and the history of iron exposure during 
growth of the cells. The other system (siderophore) is 
generally not used during growth in customary media, 
because this media do not contain siderophores. 
However, activity for siderophore uptake is also 
responsive to iron homeostasis. Clustering of the 
uptake data makes possible distinction between 
mutants with altered trafficking of specific 
components or mutants with generally altered iron 
metabolism. 
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TABLE 1. Progressive loss, in successive screens, of the high FOB uptake phenotype in some haploid strains. The 
values indicate the rate of FOB uptake compared to wild type (= 1). 
 
ORF Gene Screen 1 Screen 2 Screen 3 Screen 4 
      
YNL170W YNL170W 5.6 4.4 1.6 1.8 
YHR100C YHR100C 7.5 1.9 3 2.5 
YAL048C GON1 5.3 3.1 1.5 1 
YML088W UFO1 11.5 3 1.3 0.9 
YMR287C MSU1 5.7 0.9 0.9 nd 
YOR036W PEP12 5.6 2.2 2 1.5 
YOR123C LEO1 2.5 1.6 0.9 nd 
YOR141C ARP8 2.4 1.2 0.4 nd 
YDL198C YHM1 16.6 11.7 1.6 1.3 
YDR364C CDC40 9.1 2.1 1.0 1.6 
YKL155C RSM22 12.5 2.6 1.2 1 
YLR369W SSQ1 19.4 1.7 0.8 0.8 
YLR418C CDC73 8.6 4 2.9 1 
YNR010W CSE2 11.8 1.9 1.5 0.7 
YNR037C RSM19 5.9 2.9 0.7 0.5 
YPR160W GPH1 7.6 5.6 2.7 0.3 
YFL023W BUD27 6.9 5.8 1.3 0.7 
YCR024C YCR024C 8.9 2.5 1.1 1 
YCR071C IMG2 3.9 2 1.0 0.7 
YCR081W SRB8 9.8 4.5 1.6 0.6 
YGR063C SPT4 14.1 4 2.8 2.4 
YFL014W HSP12 12.1 4.9 1.5 0.4 
YPR133W TOM5 11.2 6.3 2.0 2.5 
YNL147W LSM7 3.8 3.6 1.5 1.2 
YGR257C MTM1 9.5 4.3 1.3 0.9 
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TABLE 2. GO proposed location of proteins corresponding to homozygous diploid mutants with high or low FOB 
uptake, ferrireductase activity, and ferrous uptake.  Mutant FOB uptake defined as Low if mean value of three assays 
≤ 0.6 x wild type, and defined as high if ≥ 1.8 x wild type.  Mutant ferrireductase activity and ferrous uptake defined 
as High or Low if statistically different from wild type (p < 0.05).  • control homozygous diploid mutant.  † low 
ferrous uptake correctable by copper to wild type levels. 
 
ORF Standard Name FOB Fe Rdx Ferrous GO Cellular  
Component 
GO Biological Process/ notes         
Plasma Membrane      
CTR1* YPR124W High High Low† Plasma membrane Ion (Cu) transport 
FRE4 YNR060W High ns ns Plasma membrane Ion (Fe) transport 
SIT1 YEL065W Low ns ns Plasma membrane Ion (Fe) transport 
       
Cytoplasm       
 YLL029W High High High Cytoplasm Unknown 
CYS4 YGR155W High High Low Cytoplasm Cysteine biosynthesis 
PEP7 YDR323C High High Low Cytoplasm Golgi to vacuole transport 
RAV1 YJR033C High High Low† Cytoplasm Vacuolar acidification 
VPS9 YML097C High High Low† Cytoplasm Protein-vacuolar targetting 
ATX1* YNL259C High High Low† Cytoplasm Ion (Cu) transport 
APS3 YJL024C High ns ns Cytoplasm Golgi to vacuole transport 
RPS11A YDR025W High ns ns Cytoplasm Protein biosynthesis 
CCR4 YAL021C High Low ns Cytoplasm Transcription regulator 
LSM1 YJL124C High Low ns Cytoplasm RNA processing 
PAT1 YCR077C High Low ns Cytoplasm RNA processing 
      
Cytoplasm/secretory      
BRO1 YPL084W High High ns Cytoplasm/endosome 
Signal transduction/ 
vacuolar transport 
SNF7 YLR025W High High ns Cytoplasm/endosome Endosome to vacuole transport 
VPS20 YMR077C High High ns Cytoplasm/endosome Endosome to vacuole transport 
CDC50 YCR094W High High ns Endosome Cell polarity / cell cycle 
VPS25 YJR102C High High ns Endosome Protein-vacuolar targetting 
VPS28 YPL065W High High ns Endosome Protein-vacuolar targetting 
VPS36 YLR417W High High ns Endosome Protein-vacuolar targetting 
VMA10 YHR039C-B High High Low Vacuole Vacuolar acidification 
VMA13 YPR036W High High Low Vacuole Vacuolar acidification 
VMA6 YLR447C High High Low Vacuole Vacuolar acidification 
VAM6 YDL077C High ns ns Vacuole Vacuolar biogenesis 
ARF1 YDL192W High High Low Cytoplasm/golgi ER to golgi transport 
PEP12 YOR036W High High Low Golgi Golgi to vacuole transport 
CCC2* YDR270 High High Low† Golgi Ion (Cu) transport 
GGA2 YHR108W High ns ns Golgi Golgi to vacuole transport 
VPS4 YPR173C High High ns Cytoplasm/ER Endosome to vacuole transport 
VPS64 YDR200C High High Low Cytoplasm/ER Protein-vacuolar targetting 
PKR1 YMR123W High High Low† ER Unknown 
VMA21 YGR105 High High Low ER Protein complex assembly 
      
Cytoplasm/nucleus      
PPZ1 YML016C High High High Cytoplasm/nucleus ion (Na) homeostasis 
BUD32 YGR262C High High ns Cytoplasm/nucleus Bud site selection 
VID28 YIL017C High High ns Cytoplasm/nucleus Regulation of gluconeogenesis 
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 YGL220 High ns ns Cytoplasm/nucleus unknown 
FYV1 YDR024W High ns Low Cytoplasm/nucleus Unknown - Dubious ORF 
DEG1 YFL001W Low High ns Cytoplasm/nucleus RNA processing 
HSP12 YFL014W Low ns ns Cytoplasm/nucleus Stress response 
RCS1(AFT1) YGL071W Low ns Low Cytoplasm/nucleus Transcription regulator  
SPT4 YGR063C High High High Nucleus RNA elongation 
CDC73 YLR418C High High ns Nucleus RNA elongation 
NPL6 YMR091 High High Low Nucleus Protein-nucleus import 
SRB8 YCR081W High High Low Nucleus Transcription regulator 
LSM7 YNL147W High ns ns Nucleus mRNA splicing 
ARP5 YNL059C High ns ns Nucleus Protein-vacuolar targetting 
TUP1 YCR084C High ns Low Nucleus Transcription regulator 
LSM6 YDR378C High Low ns Nucleus RNA processing 
SRB5 YGR104CC High Low ns Nucleus RNA elongation 
SSN8 YNL025C High Low ns Nucleus Transcription regulator 
CYC8 YBR112C High Low Low Nucleus Transcription regulator 
MED1 YPR070W High Low Low† Nucleus Transcription 
SSN3 YPL042C High Low Low Nucleus Transcription regulator 
TAF14 YPL129W High Low Low Nucleus Transcription 
EBS1 YDR206W Low ns ns Nucleus Telomere mainenance 
      
Mitochondrion      
IMG2 YCR071C High High High Mitochondrion Protein biosynthesis 
MTM1 YGR257C High High High Mitochondrion ion (Mn) transport 
TOM5 YPR133W-A High High High Mitochondrion Protein import 
 YCR024C High High High Mitochondrion Protein biosynthesis 
GGC1* YDL198C High High High Mitochondrion transport / ion (Fe) homeostasis 
FMC1 YIL098C High High ns Mitochondrion Protein complex assembly 
LPD1 YFL018C High High ns Mitochondrion Pyruvate dehydrogenase  
MRS1 YIR021W High High ns Mitochondrion Intron splicing 
POR1 YNL055C High High ns Mitochondrion Respiration / iron transport 
RSM19 YNR037C High High ns Mitochondrion Protein biosynthesis 
YME1 YPR024W High High ns Mitochondrion  Mitochondrion biogenesis 
SSQ1* YLR369W High High Low† Mitochondrion Ion (Fe) homeostasis 
GRX5 YPL059W High ns ns Mitochondrion stress response 
HEM14 YER014W High Low ns Mitochondrion Heme biosynthesis 
       
Other       
MMR1 YLR190W High High ns Bud neck Unknown 
RCY1 YJL204C High High ns Site of growth Endocytosis 
       
Unknown       
DIA2 YOR080W High High ns Unknown Invasive growth 
 YGR064W High High ns Unknown Unknown. Overlap with SPT4 
 YHR100C High High ns Unknown Unknown 
 YLR358C High High ns Unknown Unknown. Overlap with RSC2 
VPS63 YLR261C High High Low Unknown Unknown. Overlap with YPT6 
 YDR199W High ns ns Unknown Unknown. Dubious ORF 
 YKL097C High ns ns Unknown Unknown. Dubious ORF 
 YLL030C High ns ns Unknown Unknown. Dubious ORF 
BUD25 YER014C-A High Low ns Unknown Unknown. Overlap with HEM14 
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TABLE 3. Intracellular iron distribution in selected strains belonging to different phenotypic categories. Cells 
were grown overnight in YPD medium containing 10 µM 55Fe-FOB, harvested in late exponential phase of growth, 
and fractionated to determine the amount of iron in the soluble and mitochondrial fractions. Data from one 
experiment. 
 
  Whole cells 
(pmol Fe/OD) 
Mitochondria 
(pmol Fe/mg) 
Soluble  
(pmol Fe/mg) 
Mito/soluble 
strain phenotype 
category 
    
      
WT  38 7240 1265 5.72 
VMA10 I 555 21265 31015 0.69 
GGA2 II 1003 29943 49123 0.61 
BUD25 II 80 7161 4076 1.76 
TOM5 III 249 19898 24851 0.80 
POR1 III 112 14732 7955 1.85 
FMC1 III 87 5865 5325 1.10 
IMG2 III 257 54152 34422 1.57 
YGL220w III 170 22890 5813 3.94 
YLL029w III 167 30457 7323 4.16 
 
 
  19 
 
Figure 1: The complete haploid knockout collection from EUROSCARF was assayed for FOB uptake.  Data for 
strains in sequentially numbered wells in microtiter plates (x-axis) were plotted as a scattergram against uptake data 
in cpm (y-axis). Due to the presence of numerous empty wells on the assay plates, the number of assays (more than 
7000) exceeded the number of knockout strains (4847). The value for the wild type was 1009 cpm. 
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Figure 2. Colonies of haploid mutant strains that 
accumulated undissociated FOB. The indicated 
strains were spotted on a YPD-agar plate 
containing 50 µM FOB and allowed to grow for 3 
days at 30°C. The appearance of the colonies was 
recorded (left column). The rate of FOB uptake by 
each mutant was measured independently as 
described in Methods.  Values for each mutant 
were reported as n-fold the value of the wild-type 
FOB uptake rate (right column). 
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 Figure 3. Clustering of 
data for ferric reductase, iron 
uptake from ferrous salts, and 
iron uptake from various 
siderophores by diploid 
knockout strains. FeRed, 
ferric reductase activity (in 
copper deficient (-Cu), copper 
replete (+ Cu) or iron 
deficient (BPS) conditions); 
Fe(II), ferrous uptake activity; 
ENB, FOB, FCH, TAF, 
siderophore uptake activity 
(from enterobactin, 
ferrioxamine B, ferrichrome 
and triacetylfusarinine C, 
respectively). Results are 
expressed (according to the 
color scale) in log base 2 as 
the ratio mutant/wild type. 
Means from 4 experiments. 
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Figure 4. Iron uptake rates from various iron sources by 
wild-type (closed columns) or ∆fre1∆fre2 (open columns) 
cells of S. cerevisiae (S150-2B). Cells were incubated for 
30 min in complete (YPD) medium containing 1 µM of the 
indicated iron source (as 55Fe) before washing and 
determining intracellular iron. Fe(III), ferric citrate; FOB, 
ferrioxamine B; FCH, ferrichrome; TAF, 
triacetylfusarinine C; ENB, enterobactin; CG, coprogen.  
Mean ± SD from 4 experiments. 
 
  23 
 
 
Figure 5. Clustering of homozygous mutants with similar phenotypes for FOB iron uptake, ferric reductase, and 
ferrous iron uptake (left panel). Nodes of similar mutants were further grouped into three categories with different 
uptake signatures: A with low ferrous uptake, B with high or low FOB uptake, C with high FOB uptake, ferric 
reductase, and ferrous uptake. For each node, representative mutants were selected, mRNA was isolated and tested 
by Northern blotting for SIT1 and FET3 mRNA levels (right panel).  FOB, ferrioxamine B uptake; FeRed, ferric 
reductase activity (in copper deficient (-Cu), copper replete (+ Cu) or iron deficient (BPS) conditions); Fe(II), ferrous 
  24 
uptake. Results are expressed (according to the color scale) in log base 2 as the ratio mutant/wild type. Means from 4 
experiments. 
